{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:42:20Z","timestamp":1786466540981,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcte.2026.100449","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:37:02Z","timestamp":1781714222000},"page":"100449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Thyroid cancer and double-strand DNA break repair: The potential role of the MRN complex pathogenic variants"],"prefix":"10.1016","volume":"45","author":[{"given":"Sriram","family":"Gubbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Moorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashna","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deema","family":"Al-Souri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Bin-Satter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmasree","family":"Veeraraghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Klubo-Gwiezdzinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcte.2026.100449_bb0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jcte.2026.100449_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1267499","article-title":"Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors","volume":"14","author":"Minna","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcte.2026.100449_bb0015","doi-asserted-by":"crossref","first-page":"109697","DOI":"10.1016\/j.surg.2025.109697","article-title":"Targeted RNA sequencing of thyroid tumors from individuals with PTEN hamartoma tumor syndrome reveals a unique transcriptome with a predominantly RAS-like expression profile","volume":"189","author":"Plitt","year":"2025","journal-title":"Surgery"},{"issue":"5483","key":"10.1016\/j.jcte.2026.100449_bb0020","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.289.5483.1357","article-title":"PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]","volume":"289","author":"Kroll","year":"2000","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jcte.2026.100449_bb0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid Cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.jcte.2026.100449_bb0030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncy.22374","article-title":"Cytomorphologic features of NTRK-rearranged thyroid carcinoma","volume":"128","author":"Viswanathan","year":"2020","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"10.1016\/j.jcte.2026.100449_bb0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/SLA.0000000000001420","article-title":"Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients","volume":"262","author":"Yip","year":"2015","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.jcte.2026.100449_bb0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ccell.2018.07.002","article-title":"Integrated genomic analysis of H\u00fcrthle cell Cancer reveals oncogenic drivers, recurrent mitochondrial mutations, and unique chromosomal landscapes","volume":"34","author":"Ganly","year":"2018","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.jcte.2026.100449_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113826","article-title":"The genomic and evolutionary landscapes of anaplastic thyroid carcinoma","volume":"43","author":"Zeng","year":"2024","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.jcte.2026.100449_bb0050","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcte.2026.100449_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fgene.2015.00157","article-title":"DNA repair mechanisms in cancer development and therapy","volume":"6","author":"Torgovnick","year":"2015","journal-title":"Front Genet"},{"issue":"11","key":"10.1016\/j.jcte.2026.100449_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115995","article-title":"Polymorphisms of DNA repair genes in thyroid Cancer","volume":"25","author":"Gieleci\u0144ska","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: different roles in a common pathway of genome protection","volume":"12","author":"Roy","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.jcte.2026.100449_bb0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cell.2011.03.041","article-title":"Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11","volume":"145","author":"Schlacher","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jcte.2026.100449_bb0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-biochem-062917-012415","article-title":"The MRE11-RAD50-NBS1 complex conducts the orchestration of damage Signaling and outcomes to stress in DNA replication and repair","volume":"87","author":"Syed","year":"2018","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jcte.2026.100449_bb0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-biophys-051013-022737","article-title":"The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder","volume":"43","author":"Walden","year":"2014","journal-title":"Annu Rev Biophys"},{"issue":"3","key":"10.1016\/j.jcte.2026.100449_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrc1011","article-title":"ATM and related protein kinases: safeguarding genome integrity","volume":"3","author":"Shiloh","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yexcr.2014.07.004","article-title":"Exploiting DNA mismatch repair deficiency as a therapeutic strategy","volume":"329","author":"Guillotin","year":"2014","journal-title":"Exp Cell Res"},{"issue":"11","key":"10.1016\/j.jcte.2026.100449_bb0095","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1073\/pnas.73.11.4135","article-title":"Repair tracts in mismatched DNA heteroduplexes","volume":"73","author":"Wagner","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2010.05.011","article-title":"MUTYH-associated polyposis (MAP)","volume":"79","author":"Nielsen","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.jcte.2026.100449_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/endrev\/bnaf035","article-title":"DNA damage and repair in thyroid physiology and disease","volume":"47","author":"Arczewska","year":"2025","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.jcte.2026.100449_bb0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1677\/ERC-09-0020","article-title":"Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ","volume":"16","author":"Driessens","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0120","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.1038\/s41467-025-64082-x","article-title":"Structural basis for DNA break sensing by human MRE11-RAD50-NBS1 and its regulation by telomeric factor TRF2","volume":"16","author":"Fan","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jcp.25048","article-title":"Mechanisms and consequences of double-Strand DNA break formation in chromatin","volume":"231","author":"Cannan","year":"2016","journal-title":"J Cell Physiol"},{"issue":"3","key":"10.1016\/j.jcte.2026.100449_bb0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/85798","article-title":"DNA double-strand breaks: signaling, repair and the cancer connection","volume":"27","author":"Khanna","year":"2001","journal-title":"Nat Genet"},{"issue":"34","key":"10.1016\/j.jcte.2026.100449_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw7680","article-title":"Distinctive molecular features of radiation-induced thyroid cancers","volume":"11","author":"Karyadi","year":"2025","journal-title":"Sci Adv"},{"issue":"6785","key":"10.1016\/j.jcte.2026.100449_bb0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/35013089","article-title":"ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response","volume":"405","author":"Wu","year":"2000","journal-title":"Nature"},{"issue":"6785","key":"10.1016\/j.jcte.2026.100449_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/35013083","article-title":"Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products","volume":"405","author":"Zhao","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/75508","article-title":"ATM-dependent phosphorylation of nibrin in response to radiation exposure","volume":"25","author":"Gatei","year":"2000","journal-title":"Nat Genet"},{"issue":"27","key":"10.1016\/j.jcte.2026.100449_bb0155","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1038\/sj.onc.1205596","article-title":"Nbs1 promotes ATM dependent phosphorylation events including those required for G1\/S arrest","volume":"21","author":"Girard","year":"2002","journal-title":"Oncogene"},{"issue":"6778","key":"10.1016\/j.jcte.2026.100449_bb0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/35007091","article-title":"ATM phosphorylates p95\/nbs1 in an S-phase checkpoint pathway","volume":"404","author":"Lim","year":"2000","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-019-1100-5","article-title":"MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment","volume":"18","author":"Bian","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcte.2026.100449_bb0170","doi-asserted-by":"crossref","unstructured":"McPherson MT, Holub AS, Husbands AY, Petreaca RC. Mutation spectra of the MRN (MRE11, RAD50, NBS1\/NBN) break sensor in cancer cells. Cancers (Basel) 2020;12(12).","DOI":"10.3390\/cancers12123794"},{"issue":"7","key":"10.1016\/j.jcte.2026.100449_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071678","article-title":"A survey of reported disease-related mutations in the MRE11-RAD50-NBS1 complex","volume":"9","author":"Rahman","year":"2020","journal-title":"Cells"},{"issue":"5667","key":"10.1016\/j.jcte.2026.100449_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1091496","article-title":"Direct activation of the ATM protein kinase by the Mre11\/Rad50\/Nbs1 complex","volume":"304","author":"Lee","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jcte.2026.100449_bb0185","series-title":"GeneReviews(\u00ae)","article-title":"Nijmegen Breakage Syndrome","author":"Varon","year":"1993"},{"issue":"3","key":"10.1016\/j.jcte.2026.100449_bb0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(00)81174-5","article-title":"Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome","volume":"93","author":"Varon","year":"1998","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12935-021-02032-5","article-title":"DNA double-strand break repair gene mutation and the risk of papillary thyroid microcarcinoma: a case-control study","volume":"21","author":"Qin","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"7","key":"10.1016\/j.jcte.2026.100449_bb0200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/13892029113146660012","article-title":"NBN gene polymorphisms and Cancer susceptibility: a systemic review","volume":"14","author":"Berardinelli","year":"2013","journal-title":"Curr Genomics"},{"issue":"3","key":"10.1016\/j.jcte.2026.100449_bb0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molcel.2012.02.018","article-title":"Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1","volume":"46","author":"Wu","year":"2012","journal-title":"Mol Cell"},{"issue":"7033","key":"10.1016\/j.jcte.2026.100449_bb0210","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nature03442","article-title":"Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage","volume":"434","author":"Falck","year":"2005","journal-title":"Nature"},{"issue":"3a","key":"10.1016\/j.jcte.2026.100449_bb0215","first-page":"2107","article-title":"Analysis of DNA mismatch repair gene expression and mutations in thyroid tumours","volume":"26","author":"Ruschenburg","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jcte.2026.100449_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.653401","article-title":"Co-occurrence of familial non-medullary thyroid Cancer (FNMTC) and hereditary non-polyposis colorectal Cancer (HNPCC) associated Tumors-a cohort study","volume":"12","author":"Aswath","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ijc.35159","article-title":"Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways","volume":"156","author":"Pires","year":"2025","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcte.2026.100449_bb0230","article-title":"Advances of DNA damage repair-related drugs and combination with immunotherapy in tumor treatment","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jcte.2026.100449_bb0235","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaf040","article-title":"Targeting DNA repair mechanisms in cancer therapy: the role of small molecule DNA repair inhibitors","volume":"7","author":"Jeong","year":"2025","journal-title":"NAR Cancer"},{"issue":"1","key":"10.1016\/j.jcte.2026.100449_bb0240","doi-asserted-by":"crossref","first-page":"11077","DOI":"10.1038\/s41467-025-67243-0","article-title":"Repurposing clinically safe drugs for DNA repair pathway choice in CRISPR genome editing and synthetic lethality","volume":"16","author":"Macak","year":"2025","journal-title":"Nat Commun"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623726000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623726000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:47:27Z","timestamp":1786463247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623726000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"alternative-id":["S2214623726000207"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2026.100449","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid cancer and double-strand DNA break repair: The potential role of the MRN complex pathogenic variants","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2026.100449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100449"}}